ELV - Elevance Health - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ELV is currently covered by 17 analysts with an average price target of $605.85. This is a potential upside of $80.24 (15.27%) from yesterday's end of day stock price of $525.61.

Elevance Health's activity chart (see below) currently has 242 price targets and 180 ratings on display. The stock rating distribution of ELV is 84.62% BUY and 15.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.73% with an average time for these price targets to be met of 248.2 days.

Highest price target for ELV is $604, Lowest price target is $552, average price target is $605.85.

Most recent stock forecast was given by ANN HYNES from MIZUHO on 24-Apr-2024. First documented stock forecast 06-Jan-2015.

Currently out of the existing stock ratings of ELV, 44 are a BUY (84.62%), 8 are a HOLD (15.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

585

$59.39 (11.30%)

545

9 days ago

7/9 (77.78%)

$51.27 (9.61%)

52

Buy

604

$78.39 (14.91%)

564

14 days ago

10/16 (62.5%)

$72.58 (13.66%)

263

Buy

575

$49.39 (9.40%)

574

14 days ago

2/6 (33.33%)

$43.58 (8.20%)

272

Buy

600

$74.39 (14.15%)

610

14 days ago

8/12 (66.67%)

$68.58 (12.91%)

355

Buy

580

$54.39 (10.35%)

580

29 days ago

3/12 (25%)

$81.4 (16.33%)

165

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ELV (Elevance Health) average time for price targets to be met?

On average it took 248.2 days on average for the stock forecasts to be realized with a an average price target met ratio 65.73

Which analyst has the current highest performing score on ELV (Elevance Health) with a proven track record?

LANCE WILKES

Which analyst has the most public recommendations on ELV (Elevance Health)?

Lance Wilkes works at BERNSTEIN and has 15 price targets and 6 ratings on ELV

Which analyst is the currently most bullish on ELV (Elevance Health)?

Matthew Borsch with highest potential upside - $99.39

Which analyst is the currently most reserved on ELV (Elevance Health)?

Ana Gupte with lowest potential downside - -$190.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?